Lazard Asset Management
BIVV

Lazard Asset Management’s Bioverativ Inc. Common Stock BIVV Stock Holding History

Lazard Asset Management’s Portfolio BIVV Stock Details BIVV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-3,626
Closed -$195K – 1174
2017
Q4 		$195K Sell
3,626
-399
-10% -$21.8K ﹤0.01% 877
2017
Q3 		$229K Buy
+4,025
New +$236K ﹤0.01% 769

Other funds holding BIVV

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
ACS
Archford Capital Strategies Swansea, Illinois $987M AUM 29.31% 1-Year Est. Return

Lazard Asset Management's BIVV Position: Q1 2018 in Review

Lazard Asset Management sold out of Bioverativ Inc. Common Stock (BIVV) in Q1 2018, closing a stake of 3,626 shares — an estimated $195K sold.

Lazard Asset Management first reported a position in BIVV in Q3 2017 and held it in 2 quarters. The position peaked at $229K in Q3 2017. 2 funds tracked by Wall St. Rank hold BIVV as of Q1 2018.

  • Lazard Asset Management reported no remaining Bioverativ Inc. Common Stock position as of Q1 2018 after selling out during the quarter.
  • Lazard Asset Management sold 3,626 Bioverativ Inc. Common Stock shares in Q1 2018, an estimated $195K.
  • Lazard Asset Management first reported a position in Bioverativ Inc. Common Stock in Q3 2017 and held it in 2 quarters.
  • Lazard Asset Management's Bioverativ Inc. Common Stock position peaked at $229K in Q3 2017.
  • 2 funds tracked by Wall St. Rank held Bioverativ Inc. Common Stock as of Q1 2018.

Based on Lazard Asset Management's 13F filing for Q1 2018, filed 14 May 2018.